Impact of the L-arginine-Nitric Oxide Pathway and Oxidative Stress on the Pathogenesis of the Metabolic Syndrome

Table 1: The National Cholesterol Education Program's Adult Treatment Panel III (NCEP: ATP III , 2001)

NCEP: ATP III,2001

3 or more of the following:

Central obesity: waist circumference >102 cm (male), >88 cm (female)

Hypertriglyceridaemia: triglycerides ≥1·7 mmol/L

Low HDL cholesterol: <1·0 mmol/L (male), <1·3 mmol/L (female)

Hypertension: blood pressure ≥130/85 mmHg or medication

Fasting plasma glucose ≥6·1 mmol/L